Gautam Chukka's Stock Coverage
| TVRDTvardi Therapeutics | Oct 20, 2026 | BUY | Initiated | $8.00 | 1Ratings | -20.10% | ||
| FDMT4D Molecular Therapeutics | Oct 06, 2026 | BUY | Reiterated | $25.00 | 1Ratings | -5.20% | ||
| PVLAPalvella Therapeutics | Sep 21, 2026 | BUY | Reiterated | $240.00 | 1Ratings | -4.70% | ||
| ADAGAdagene | Sep 10, 2026 | BUY | Initiated | $9.00 | 1Ratings | -24.10% | ||
| TENXTenax Therapeutics | Aug 11, 2026 | HOLD | Downgraded | $5.00 | 3Ratings | -88.10% |
Disclaimer: TipRanks collects analysts’ ratings and price targets by scanning publicly available reports on financial websites and by receiving reports from analysts, firms, or customers. The information and statistics displayed might not be accurate, complete, or up-to-date. The analyst ratings provided are the sole responsibility of the source publication. TipRanks holds no liability over the analysts' information, price targets, ratings, or opinions expressed. See how TipRanks ranks experts and calculates performance.
Send Us Reports
If you receive reports that you think we are missing, we will thank you with a free Ultimate upgrade!
Learn More >Gautam Chukka activity FAQ
What is the performance of Gautam Chukka's recommendations?
The percentage of profitable recommendations made by Gautam Chukka is 0.00%, and the average return per transaction is -28.40%.
What stocks does Gautam Chukka cover?
Gautam Chukka mostly covers Tvardi Therapeutics, 4D Molecular Therapeutics, Palvella Therapeutics stocks.
What was Gautam Chukka's most profitable rating?
Gautam Chukka’s most profitable rating was a buy on Palvella Therapeutics stock on Sep 21, 2026. The return on the trade was -4.70%.
Where can I see a list of stock analyst ratings?
You can see a list of daily stock analyst ratings here.
What are the most recommended stocks by analysts?
You can see a list of the most recommended stocks by analysts here